Finasteride
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
Finasteride is an oral 5-alpha reductase inhibitor best known for treating male pattern hair loss (androgenetic alopecia) and benign prostatic hyperplasia (BPH). It works by lowering levels of dihydrotestosterone (DHT), a potent androgen derived from testosterone that drives both scalp follicle miniaturization and prostate growth.
It is one of the more thoroughly studied compounds in this reference. Large randomized trials support its use for slowing hair loss and easing prostate symptoms, and it is FDA-approved for both indications as a prescription medication.
In the context of testosterone therapy, finasteride is often categorized as an ancillary. Because TRT can increase DHT, some men and clinicians consider a 5-alpha reductase inhibitor to manage androgenic side effects such as hair thinning, though this is a clinical decision that weighs several tradeoffs.
How it works
Finasteride is a competitive inhibitor of the type II (and type III) isoenzymes of 5-alpha reductase, the enzyme that converts testosterone into DHT. By blocking this step, it reduces serum DHT by roughly two-thirds and lowers DHT within tissues such as the scalp and prostate even further.
Because DHT — not testosterone itself — is the primary driver of follicular miniaturization and prostate enlargement, reducing it can slow or partially reverse these processes. Testosterone levels themselves generally remain within the normal range, since finasteride acts downstream on the conversion step rather than on testosterone production.
Reported benefits
- Slowed progression of male pattern hair loss, with some regrowth reported in clinical trials
- Reduced prostate volume and improved urinary symptoms in benign prostatic hyperplasia
- Lower serum and tissue DHT, studied as a way to manage androgenic effects on TRT
These are studied and reported effects, not guaranteed outcomes, and response varies between individuals.
Considerations & side effects
The most commonly reported side effects are sexual in nature — decreased libido, erectile difficulty, and reduced ejaculate volume — typically affecting a small percentage of users in clinical trials. A subset of users report symptoms that persist after discontinuation, sometimes described as post-finasteride syndrome; this remains an area of ongoing research and debate.
Finasteride is contraindicated in women who are or may become pregnant, as DHT suppression can affect development of a male fetus; broken or crushed tablets should not be handled in that setting. It can also lower PSA readings, which is relevant for prostate cancer screening. It is a prescription medication and is not a substitute for evaluation and monitoring by a qualified clinician.
Frequently asked
What is finasteride?
Finasteride is a 5-alpha reductase inhibitor — an oral medication that blocks the conversion of testosterone into dihydrotestosterone (DHT), the androgen most implicated in male pattern hair loss and prostate enlargement.
Is finasteride FDA-approved?
Yes. Finasteride is FDA-approved as a prescription drug: at 1 mg (Propecia) for male pattern hair loss and at 5 mg (Proscar) for benign prostatic hyperplasia. It is not approved for use in women, particularly those who are or may become pregnant.
Why is finasteride discussed alongside TRT?
Testosterone therapy can raise DHT and, in some men, accelerate androgenic hair loss. Finasteride is commonly studied and used as an ancillary to blunt DHT-related effects, though it is one of several options a clinician may weigh.
What are the main side-effect concerns?
The most commonly reported concerns are sexual — reduced libido, erectile difficulty, and lower ejaculate volume. Most cases are reported as reversible, but some users describe persistent symptoms after stopping, an area still being studied.
References
Related compounds
Aromatase inhibitor (AI). Used to control estrogen levels during TRT. Brand name Arimidex.
A long-acting dopamine agonist used to lower elevated prolactin, which can impair libido and erectile function on TRT or with certain compounds. Dosed only twice weekly thanks to its ~65-hour half-life; monitor for valvular effects at higher doses.
A SERM used off-label in men to stimulate LH/FSH and raise natural testosterone while preserving sperm production, and as a post-cycle/fertility agent. It is a racemic mixture of enclomiphene and the long-lived estrogenic zuclomiphene.